Related Experiment Video

Updated: Oct 19, 2025

Model of Ischemia and Reperfusion Injury in Rabbits
06:11

Model of Ischemia and Reperfusion Injury in Rabbits

Published on: November 3, 2023

1.4K

Myocardial Ischemia-Reperfusion Injury: Therapeutics from a Mitochondria-Centric Perspective

Manli Zhou1, Yunfeng Yu2, Xiaoxin Luo2

  • 1College of Traditional Chinese Medicine, Hunan University of Traditional Chinese Medicine, Changsha, China, ZMLadvancer@163.com.

Cardiology
|September 21, 2021
PubMed

Insights

Myocardial ischemia-reperfusion injury worsens heart damage despite blood flow restoration. Targeting the mitochondrial quality control system offers a new therapeutic strategy for treating this condition.

Area of Science:

  • Cardiology
  • Mitochondrial Biology
  • Pathophysiology

Background:

  • Coronary arterial disease is a leading cause of cardiovascular disease.
  • Myocardial ischemia-reperfusion (I/R) injury is a significant clinical challenge following acute myocardial infarction.
  • Current treatments focus on immediate recanalization, often overlooking reperfusion-induced damage.

Purpose of the Study:

  • To elucidate the role of the mitochondrial quality control system in myocardial I/R injury.
  • To explore mitochondria as a potential therapeutic target for I/R injury.

Main Methods:

  • Review of existing literature on mitochondrial dynamics and I/R injury.
  • Analysis of the interplay between mitochondrial fusion, fission, biogenesis, and autophagy.
  • Examination of the link between mitochondrial dysfunction, oxidative stress, and myocardial injury.

Main Results:

  • Mitochondrial dysfunction and oxidative stress are key contributors to I/R injury pathogenesis.
  • The mitochondrial quality control system, involving dynamics and autophagy, is crucial for cell homeostasis and survival.
  • Impaired mitochondrial quality control exacerbates I/R-induced myocardial damage.

Conclusions:

  • The mitochondrial quality control system is critically involved in myocardial I/R injury.
  • Modulating mitochondrial dynamics and quality control presents a promising therapeutic avenue for I/R injury treatment.
  • Targeting mitochondria could mitigate pathological sequelae and improve outcomes after myocardial infarction.

Keywords:
Drug therapyMitochondrial quality control systemMitochondrial stasisMitochondrial transplantationProteolysis-targeting chimerasStem-cell therapy

More Related Videos

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury07:23

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

6.4K
Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.3K

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.3K
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
13.1K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
53
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
71
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
32
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
8.4K